Sponsored by F. Hoffmann-La Roche Ltd, in collaboration with Vall d’Hebron Institute of Oncology (VHIO), a first-in-human clinical trial was…
María Vieito
Advances driven by research have led to significant developments in better understanding the molecular taxonomy of cancer and therapeutic breakthroughs…
Presented today at the ESMO Congress 2024* by Maria Vieito, Medical Oncologist at the Vall d’Hebron University Hospital, CORE Phase…
Published in the journal Clinical Cancer Research (1), preliminary results of a two-part, phase I first-in-human study show encouraging antitumor…
